Compuware and Wipro Jointly Launch a Mainframe Center of Excellence
25.7.2017 12:00 | NASDAQ OMX
Best Practices Empower Large Global Enterprises to Better Leverage High-Value Systems of Record in Fast-Moving Digital Markets
- Modernized mainframe systems of record are critical digital investments for large global enterprises-delivering unmatched reliability, scalability, performance and security.
- Unfortunately, outdated processes and tools often prevent enterprises from adapting their existing mainframe applications to meet changing business needs with the same agility achieved on other platforms.
- Compuware and Wipro are addressing this challenge through a joint Mainframe Center of Excellence (CoE) that enables Wipro to formulate best practices for achieving mainframe agility and cross-platform DevOps integration, as well as gain mastery of Compuware's software.
- By leveraging Compuware's software and Wipro's best practices, enterprises can gain the combined competitive advantages of scale and speed, while also successfully navigating a difficult generational shift in mainframe stewardship.
DETROIT, July 25, 2017 (GLOBE NEWSWIRE) -- Compuware Corporation today announced the launch of a Mainframe Center of Excellence (CoE) in partnership with Wipro Limited (NYSE:WIT) (BSE:507685) (NSE:WIPRO), a leading global information technology, consulting and business process services company. The Mainframe CoE will be dedicated to helping large global enterprises better leverage their systems of record for competitive advantage in fast-moving digital markets.
Enterprise IT leaders grapple with mainframe environments that are mired in traditional "waterfall" development, inadequately integrated into cross-platform DevOps workflows and foreign to the Millennials who will ultimately be responsible for the platform's future. The innovative Mainframe CoE, which Wipro will operate, strengthens the company's ability to transform customers' mainframe environments and drive competitive advantage through the adoption of cross-platform Agile and DevOps best practices.
Compuware is enabling Wipro technical consultants, via hands-on access to Compuware's proven solutions and ongoing training, to establish industry-leading expertise in: agile development on the mainframe, integration of mainframe dev/test/release processes into multi-platform enterprise DevOps toolchains, and modernized workspaces that empower Millennials to effectively work with mainframe resources in the same manner as they work with other platforms. Wipro's extensive experience along with this deep expertise of Compuware's mainframe software, will provide an empirical foundation for the CoE's best-practice recommendations.
The collaboration also serves as another resource for continual improvement towards an Agile mainframe. With direct experience using Compuware's products to discover better ways to leverage mainframe applications and data, Wipro can assist their enterprise clientele in achieving greater innovation throughput and quality that's essential to competing in the digital age.
Benefits to enterprise customers include:
- Dramatically improved digital agility
- Substantial reductions in mainframe TCO
- Greater business value and competitive differentiation from investments in mainframe applications, data and processing power
- Successful transition of mainframe stewardship from Baby Boomers to less specifically mainframe-experienced Millennials
For large global enterprises, mainframes are irreplaceable and invaluable systems of record. They are repositories of business logic, customer data and other intellectual property that have been carefully and continuously honed over many decades. Unfortunately, a combination of outmoded processes, tools and culture renders many enterprises incapable of quickly adapting their systems of record as necessary to fulfill the relentlessly changing needs of the business.
This lack of speed is in marked contrast to the Agile, DevOps and Continuous Delivery disciplines that they have been able to apply to applications running on other platforms such as private and public clouds. This can greatly hamper competitiveness of large enterprises vis-a-vis smaller, nimbler companies. The new Mainframe CoE addresses this critical challenge by capturing and sharing best practices for optimizing mainframe agility and mainstreaming of the mainframe into broader multi-platform enterprise architectures.
"Compuware's focus on mainframe Agility and DevOps enablement aligns with our own approach to mainframe applications. We believe this CoE will accelerate the digital journeys for our global clients especially those of large enterprises," said Jatin Mehta, Head, Mainframe Application Services, Wipro Limited. "By leveraging Compuware's technology in the context of a broader enterprise strategy for digital excellence, Wipro can substantially enhance our enterprise customers' ability to innovate in a marketplace where rapid parity is a must," he added.
"Partnering with Wipro on a mainframe-centric CoE affords us a great opportunity to demonstrate exactly how our technology supports the kind of aggressive evolution enterprises absolutely must bring to bear on their mainframes. This will be key to their ability to survive and thrive in an innovation-based economy," said Compuware CEO Chris O'Malley. "We look forward to a long and fruitful collaboration with Wipro-which clearly has tremendous visibility into both the nature of the enterprise's current mainframe challenges and the path to helping these users overcome those challenges in a timely manner."
Compuware empowers the world's largest companies to excel in the digital economy by fully leveraging their high-value mainframe investments. We do this by delivering highly innovative solutions that uniquely enable IT professionals with mainstream skills to manage mainframe applications, data, and platform operations. Learn more at compuware.com.
Follow us on:
For Sales and Marketing Information
Compuware Corporation, One Campus Martius, Detroit MI 48226, 800-521-9353, compuware.com.
Copyright © 2017 Compuware Corporation. Compuware, the Compuware logo, and Topaz are registered or pending registration with the U.S. Patent and Trademark Office, and may be registered or pending registration in other countries.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Compuware Corporation via Globenewswire
Om NASDAQ OMX
NASDAQ OMX (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.
Følg saker fra NASDAQ OMX
Registrer deg med din epostadresse under for å få de nyeste sakene fra NASDAQ OMX på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra NASDAQ OMX
Brand Industrial Services Announces Agreement to Acquire Venko Groep BV16.8.2017 19:40 | Pressemelding
Complementary core strengths provide broader range of services for customers KENNESAW, GA, Aug. 16, 2017 (GLOBE NEWSWIRE) -- Brand Industrial Services, known as BrandSafway, has signed an agreement to acquire Venko Groep BV, a portfolio company of Mentha Capital. Venko will become a part of the Brand Energy & Infrastructure Services (Brand) group. "We are very pleased to announce the agreement with Venko," said Bill Hayes, President and CEO of BrandSafway. "Our combined customers in Europe will benefit from a broader range of solutions and greater depth of expertise in access, insulation and coatings. Bringing Venko's highly specialized knowledge in coatings to BrandSafway will provide the expertise we need to expand our services in the offshore market worldwide." Based in the Netherlands, with a focus on operations in the North Sea area, Venko is a leading offshore and onshore coatings maintenance provid
Abeona Therapeutics Announces Pivotal Expansion of ABO-102 Gene Therapy Clinical Trials in Sanfilippo Syndrome Type A16.8.2017 15:38 | Pressemelding
NEW YORK and CLEVELAND, Aug. 16, 2017 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq:ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel gene therapies for life-threatening rare diseases, today announced the pivotal expansion of its gene therapy clinical trials for patients with MPS IIIA in the USA, Europe and Australia. "We have completed the necessary regulatory and ethical committee approvals and site initiations in Europe and Australia in order to accelerate enrollment," stated Juan Ruiz, M.D., Ph.D., Abeona's Chief Medical Officer. "We remain very encouraged by the improvements observed in clinically relevant biomarkers post-dosing of ABO-102, including durable reductions in heparan sulfate measured in the CNS, reduction of organ disease pathology, and signals of CNS improvement or stabilization at one-year follow-up in Cohort 1 subjects, and look forward to providing a more fulsome clinical update at important clinical
CallidusCloud Wins Eight Gold Stevies® in the 2017 International Business Awards16.8.2017 14:00 | Pressemelding
CallidusCloud Lead to Money suite recognized as Best B2B New Product of the Year. LeadRocket voted Best New Product or Service of the Year in the Software - Lead Generation Solution category. DUBLIN, Calif., Aug. 16, 2017 (GLOBE NEWSWIRE) -- Callidus Software Inc. (NASDAQ:CALD), a global leader in cloud-based sales, marketing, learning, and customer experience solutions, announced today that it was named the winner of eight Gold Stevie® awards in the 2017 International Business Awards. "The eight Stevie® awards earned highlight CallidusCloud's momentum, commitment to excellence, passion for innovation and customer orientation," said Leslie Stretch, president and CEO of CallidusCloud. "They also recognize the benefits that the Lead to Money suite, honored as the Best New Product in Business-to-Business, accrues to its customers in terms of enabling faster, bigger, and more profitable sales." CallidusCloud's Go
Ascom Myco and Koutio Médipôle optimize care communications and responsiveness16.8.2017 08:00 | Pressemelding
Ascom Holding AG / Ascom Myco and Koutio Médipôle optimize care communications and responsiveness . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. Enabled by the Ascom Myco smart device, the new Koutio Médipôle is realizing improved care delivery through seamless information flow from the point of care to anywhere. BAAR, Switzerland, Aug. 16, 2017 (GLOBE NEWSWIRE) -- The new Koutio Médipôle hospital in the New Caledonian capital Nouméa, located in the southwest Pacific Ocean, has optimized patient care communications and responsiveness for the new 645-bed facility by deploying Ascom Myco Wi-Fi devices to support clinician teams and Ascom Myco Wi-Fi/GSM handsets, used across paramedic teams. The Ascom solution is seamlessly aligned with clinical workflow and applications (nurs
VistaJet Harnesses the Power of the American Eclipse to Offer Customers a Rare Viewing Opportunity15.8.2017 18:40 | Pressemelding
VistaJet invites customers to fly in parallel with an astronomical anomaly NEW YORK, Aug. 15, 2017 (GLOBE NEWSWIRE) -- VistaJet, the first and only global aviation company, will be offering customers the opportunity to experience and chase the American Solar Eclipse, appearing for the first time in 99 years on August 21, 2017. A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/c0c41d7d-7ad9-4a46-9d2d-dcc1148b4772 The coast-to-coast National Eclipse and astronomical phenomenon will be visible in the United States from approximately 10:15AM PST, with the sun disappearing behind the moon from the Oregon coast, passing through 14 states to South Carolina. Without being in this 70-mile strip, Americans will not be able to see the sun eclipsed in totality. With unparalleled experience flying into and out of the hardest to reach destinations, VistaJet is offer
NGX Bio Raises $3 Million to Fund Growth of Its DNA Sequencing Marketplace15.8.2017 17:00 | Pressemelding
SAN FRANCISCO, Aug. 15, 2017 (GLOBE NEWSWIRE) -- NGX Bio, Inc., (www.NGXbio.com) the premier marketplace for online DNA sequencing services, announced it has closed a $3 million funding round. The round was led by 180 Degree Capital Corp. (NASDAQ:TURN) and included Third Kind Venture Capital, Lateral Capital, the Band of Angels and the Berkeley Angel Network, as well as other investors. NGX Bio was founded in 2014 to provide streamlined, on-line access to next-generation sequencing services for clients seeking high quality, rapid and cost-effective sequencing of both human and non-human samples globally. Demand for sequencing services is growing exponentially. NGX Bio's platform matches the sequencing needs of customers with providers who have available sequencing capacity. Customers are able to purchase a wide range of sequencing services for their samples using NGX Bio's online ordering tools. NGX Bio offers these services through numerous and deep relationships with its
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom